February 7, 2020
Researchers from SickKids recently received $7.5 million in funding to study the microbiome and immunology. These team grants were awarded by CIHR and partners in the Canadian Microbiome Initiative 2 and Human Immunology Initiative competitions.
November 9, 2020
Even when genetic conditions can be clearly traced to a root cause in the DNA, how those conditions present can vary. A team from the International 22q11.2 Deletion Syndrome Brain Behavior Consortium (IBBC), led by SickKids, discovered they needed …
March 3, 2021
A SickKids-led randomized clinical trial found intermittent pulse oximetry monitoring of infants with stabilized bronchiolitis is preferred to continuous pulse oximetry monitoring.
March 16, 2021
SickKids study shows promising proof-of-concept for an innovative CRISPR-Cas9 treatment strategy.
November 18, 2021
Dr. Jean-Philippe Julien is one of Canada’s Top 40 Under 40® for 2021, recognized for his contributions to antibody research and commitment to research translation.
November 25, 2021
Researchers have identified for the first time a potential biomarker that could be used as a predictive tool in the care of children with CFSPID, an inconclusive cystic fibrosis diagnosis.
January 27, 2022
Immune checkpoint inhibitors may help treat some childhood cancers that are resistant to more common cancer treatments such as chemotherapy and radiation therapy.
April 5, 2022
Dr. Bhutta receives the John Dirks Canada Gairdner Global Health Award in recognition of global health research and interventions in the ‘first 1,000 days’ of life.
May 13, 2022
Annual commercialization event offers attendees access to emerging therapeutic and diagnostic SickKids technologies with high potential for market disruption and clinical impact.
August 13, 2020
SickKids is leading a research study that will look at the effects of physical distancing, masking, hand hygiene and other health and safety measures for students and teachers returning to school during the COVID-19 pandemic.